title: Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption.
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Lanzafame
authors.forename: Emanuela
authors.initials: E
authors.lastname: Lattuada
authors.forename: Martina
authors.initials: M
authors.lastname: Gottardi
authors.forename: Dario
authors.initials: D
authors.lastname: Antolini
authors.forename: Ercole
authors.initials: E
authors.lastname: Concia
authors.forename: Sandro
authors.initials: S
authors.lastname: Vento
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D018791:CD4 Lymphocyte Count; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D012367:RNA, Viral / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D028761:Withholding Treatment
chemical_list: D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors